Publications – KalVista Pharmaceuticals

Patients & Caregivers
- About HAE
Healthcare Professionals
Clinical Trials
Presentations & Publications
Investors & News

About
Science
Pipeline
Careers
- Careers
- Job Openings
Contact

Presentations & Publications

We are committed to rigorous science and innovative drug development, and we are excited to share our ongoing progress.

Explore Our
Virtual Medical Booth

Filtered (2)

Filters

Reset all ×
HAE burden of treatment data ×
2023 ×

Apply Reset

Topic

Sebetralstat (KVD900) in HAE clinical program (0)
HAE attack journey data (0)
HAE burden of treatment data (2)
Oral Factor XIIa inhibitor (0)
Kallikrein-Kinin System science (0)

Forum

Medical Meeting (2)
Publication (0)

Year

2023 (2)
2022 (1)
2024 (11)

Show (2)

Cancel

Apply Reset

Showing 2 out of 2

Treatment Patterns Among Individuals with Hereditary Angioedema in the United States

Tachdjian R, Chang R, DerSarkissian M, Cribbs KA, Lahue BJ, Czado S, Desai V

ACAAI 2023

Targeted Literature Review to Assess the Studies Supporting Short-term Prophylactic Treatment Options for the Preprocedural Prevention of Attacks in Patients With Hereditary Angioedema

Riedl MA, Bernstein JA, Lumry WR, Audhya PK, Smith MD, Yea CM

WSAAI 2023

About

Management team

Board of Directors

Science

Pipeline

Sebetralstat

Oral Factor XIIa Inhibitor

Careers

Job Openings

Contact

KalVista Terms of Use Privacy Policy